Retusin is primarily used in research settings for its biological activity, particularly as an inhibitor of certain enzymes involved in inflammation and cancer progression. It has shown potential in studies related to anti-cancer therapy due to its ability to interfere with cell signaling pathways that promote tumor growth. Additionally, retusin exhibits antioxidant properties, making it of interest in developing treatments for oxidative stress-related conditions. Its role in modulating immune responses also supports its investigation in anti-inflammatory applications. Due to its natural origin and structural properties, it is studied for use in pharmaceuticals and as a lead compound in drug development.